Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Hybrid Cross-sectional and Prospective Study to Assess Patient Characteristics, Disease Burden, Disease Control, Phenotypes, Endotypes, and Outcomes in a Real-world Setting in Patients With Asthma

NCT07556159 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT07556159
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07556159 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Hybrid Cross-sectional and Prospective Study to Assess Patient Characteristics, Disease Burden, Disease Control, Phenotypes, Endotypes, and Outcomes in a Real-world Setting in Patients With Asthma
Lead sponsor
Sanofi
Phase
Observational
Overall status
Recruiting
Start date
April 1, 2026
Completion date
April 4, 2029
Enrollment
2,500 (estimated)
Sites
71

Conditions

As the registry lists them; a condition with its own page is linked.

asthma